GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,408.50p
   
  • Change Today:
    -46.00p
  • 52 Week High: 1,671.00p
  • 52 Week Low: 1,264.00p
  • Currency: UK Pounds
  • Shares Issued: 4,085.49m
  • Volume: 8,541,556
  • Market Cap: £57,544m
  • RiskGrade: 129

Regulatory News

Transaction in Own Shares 11-Jul-2025 07:00 RNS
Transaction in Own Shares 10-Jul-2025 07:00 RNS
Transaction in Own Shares 09-Jul-2025 07:00 RNS
Transaction in Own Shares 08-Jul-2025 07:00 RNS
GSK completes acquisition of efimosfermin for SLD 07-Jul-2025 16:00 RNS
Transaction in Own Shares 07-Jul-2025 07:00 RNS
Transaction in Own Shares 04-Jul-2025 07:00 RNS
Transaction in Own Shares 03-Jul-2025 07:00 RNS
Transaction in Own Shares 02-Jul-2025 07:00 RNS
Total Voting Rights 01-Jul-2025 15:00 RNS
Transaction in Own Shares 01-Jul-2025 07:00 RNS
Transaction in Own Shares 30-Jun-2025 07:00 RNS
Transaction in Own Shares 27-Jun-2025 07:00 RNS
Transaction in Own Shares 26-Jun-2025 07:00 RNS
Transaction in Own Shares 25-Jun-2025 07:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,408.50p
Change Today -46.00p
% Change -3.16 %
52 Week High 1,671.00p
52 Week Low 1,264.00p
Volume 8,541,556
Shares Issued 4,085.49m
Market Cap £57,544m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.61% below the market average45.61% below the market average45.61% below the market average45.61% below the market average45.61% below the market average
43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average43.48% above the sector average
Price Trend
9.11% above the market average9.11% above the market average9.11% above the market average9.11% above the market average9.11% above the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Income
75.41% above the market average75.41% above the market average75.41% above the market average75.41% above the market average75.41% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
31.86% below the market average31.86% below the market average31.86% below the market average31.86% below the market average31.86% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

What The Brokers Say

Strong Buy 3
Buy 2
Neutral 16
Sell 3
Strong Sell 0
Total 24
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 15-May-25 20-Feb-25
Paid 10-Jul-25 10-Apr-25
Amount 16.00p 16.00p

Trades for 11-Jul-2025

Time Volume / Share Price
16:09 0 @ 1,409.50p
16:09 0 @ 1,409.50p
15:48 1 @ 1,411.50p
15:52 1 @ 1,409.50p
15:47 3 @ 1,411.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page